mk 0663 has been researched along with Cardiotoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamed, NS; Khateeb, S; Taha, EF | 1 |
1 other study(ies) available for mk 0663 and Cardiotoxicity
| Article | Year |
|---|---|
Etoricoxib nanostructured lipid carriers attenuate inflammation by modulating Cyclooxygenase-2 signaling and activation of nuclear factor-κB-p65 pathways in radiation-induced acute cardiotoxicity in rats.
Topics: Animals; Cardiotoxicity; Cyclooxygenase 2; Etoricoxib; Humans; Inflammation; Lipids; NF-kappa B; Rats | 2023 |